Novel Mechanism, Drug Target and Therapy in Epilepsy

Overview

Journal Neurosci Bull

Specialty Neurology

Date 2024 Apr 24

PMID 38658515

Authors

Cenglin Xu

Yi Wang

Zhong Chen

Affiliations

Soon will be listed here.

References

Liu X, Zhang Y, Zhao Y, Zhang Q, Han F . The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy. Neurosci Bull. 2024; 40(5):621-634. PMC: 11127907. DOI: 10.1007/s12264-024-01193-3. View

Foulsham W, Dohlman T, Mittal S, Taketani Y, Singh R, Masli S . Thrombospondin-1 in ocular surface health and disease. Ocul Surf. 2019; 17(3):374-383. PMC: 6708501. DOI: 10.1016/j.jtos.2019.06.001. View

Okoh J, Mays J, Bacq A, Oses-Prieto J, Tyanova S, Chen C . Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nat Commun. 2023; 14(1):7364. PMC: 10645975. DOI: 10.1038/s41467-023-42922-y. View

Chechneva O, Mayrhofer F, Daugherty D, Pleasure D, Hong J, Deng W . Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol Dis. 2011; 44(1):63-72. PMC: 3153572. DOI: 10.1016/j.nbd.2011.06.004. View

. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(4):357-375. PMC: 6416168. DOI: 10.1016/S1474-4422(18)30454-X. View

Shen Y, Gong Y, Ruan Y, Chen Z, Xu C . Secondary Epileptogenesis: Common to See, but Possible to Treat?. Front Neurol. 2021; 12:747372. PMC: 8686764. DOI: 10.3389/fneur.2021.747372. View

Zhou Y, Wang Y, Yang L . Stem Cell Transplantation Represents a New Strategy for the Treatment of Epilepsy. Neurosci Bull. 2024; 40(5):673-676. PMC: 11127894. DOI: 10.1007/s12264-024-01208-z. View

Bershteyn M, Broer S, Parekh M, Maury Y, Havlicek S, Kriks S . Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy. Cell Stem Cell. 2023; 30(10):1331-1350.e11. PMC: 10993865. DOI: 10.1016/j.stem.2023.08.013. View

Chen Z, Maturana M, Burkitt A, Cook M, Grayden D . High-Frequency Oscillations in Epilepsy: What Have We Learned and What Needs to be Addressed. Neurology. 2021; 96(9):439-448. DOI: 10.1212/WNL.0000000000011465. View

10.

Cheng Y, Zhai Y, Yuan Y, Wang Q, Li S, Sun H . The Contributions of Thrombospondin-1 to Epilepsy Formation. Neurosci Bull. 2024; 40(5):658-672. PMC: 11127911. DOI: 10.1007/s12264-024-01194-2. View

11.

Yang J, Liu Y, Wang Y, Ge B, Wang Y, Wang Q . Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats. Neurosci Bull. 2023; 40(5):577-593. PMC: 11127903. DOI: 10.1007/s12264-023-01140-8. View

12.

Zhang S, Guo X, Huang W, Xu C . mTORC2: The "Ace in the Hole" for a Broader Control of Epileptic Seizures?. Neurosci Bull. 2024; 40(5):677-679. PMC: 11127853. DOI: 10.1007/s12264-024-01187-1. View

13.

Ye H, Chen C, Weiss S, Wang S . Pathological and Physiological High-frequency Oscillations on Electroencephalography in Patients with Epilepsy. Neurosci Bull. 2023; 40(5):609-620. PMC: 11127900. DOI: 10.1007/s12264-023-01150-6. View

14.

Shen Y, Gong Y, Da X, Gao S, Zhang S, Sun M . Low-frequency Stimulation at the Subiculum Prevents Extensive Secondary Epileptogenesis in Temporal Lobe Epilepsy. Neurosci Bull. 2024; 40(5):564-576. PMC: 11127896. DOI: 10.1007/s12264-023-01173-z. View

15.

Xu C, Wang Y, Zhang S, Nao J, Liu Y, Wang Y . Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy. Ann Neurol. 2019; 86(4):626-640. DOI: 10.1002/ana.25554. View

16.

Wu P, Cao B, Tian F, Gao Z . Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil. Neurosci Bull. 2023; 40(5):594-608. PMC: 11127901. DOI: 10.1007/s12264-023-01138-2. View

17.

Ruan Y, Xu C, Lan J, Nao J, Zhang S, Fan F . Low-frequency Stimulation at the Subiculum is Anti-convulsant and Anti-drug-resistant in a Mouse Model of Lamotrigine-resistant Temporal Lobe Epilepsy. Neurosci Bull. 2020; 36(6):654-658. PMC: 7271341. DOI: 10.1007/s12264-020-00482-x. View

18.

Xu C, Zhang S, Gong Y, Nao J, Shen Y, Tan B . Subicular Caspase-1 Contributes to Pharmacoresistance in Temporal Lobe Epilepsy. Ann Neurol. 2021; 90(3):377-390. DOI: 10.1002/ana.26173. View

19.

Vezzani A, Balosso S, Ravizza T . Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol. 2019; 15(8):459-472. DOI: 10.1038/s41582-019-0217-x. View

20.

Kobayashi M, Buckmaster P . Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci. 2003; 23(6):2440-52. PMC: 6741996. View